关注
Victoria (Tori) Klein
Victoria (Tori) Klein
Postdoctoral Research Fellow, National Institutes of Health (NIH)
在 nih.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lipophilic permeability efficiency reconciles the opposing roles of lipophilicity in membrane permeability and aqueous solubility
MR Naylor, AM Ly, MJ Handford, DP Ramos, CR Pye, A Furukawa, ...
Journal of medicinal chemistry 61 (24), 11169-11182, 2018
1382018
Understanding and improving the membrane permeability of VH032-based PROTACs
VG Klein, CE Townsend, A Testa, M Zengerle, C Maniaci, SJ Hughes, ...
ACS Medicinal Chemistry Letters 11 (9), 1732-1738, 2020
972020
Amide-to-ester substitution as a strategy for optimizing PROTAC permeability and cellular activity
VG Klein, AG Bond, C Craigon, RS Lokey, A Ciulli
Journal of medicinal chemistry 64 (24), 18082-18101, 2021
812021
Drug‐Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side‐Chain Lipophilicity
A Furukawa, J Schwochert, CR Pye, D Asano, QD Edmondson, ...
Angewandte Chemie International Edition 59 (48), 21571-21577, 2020
562020
Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives
VG Klein, WM Bray, HY Wang, Q Edmondson, J Schwochert, S Ono, ...
ACS Chemical Biology, 2021
62021
Beyond Rule of 5 Drug Discovery: Investigating the Drug-like Properties of Cyclic Peptide
V Klein
2020
Beyond Rule of 5 Drug Discovery: Investigating the Drug-Like Properties of Cyclic Peptide Natural Products and PROTACs
V Klein
University of California, Santa Cruz, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–7